Explore This Research Center

Overview

The Diabetes Unit at Mass General is recognized for its longstanding excellence in diabetes research and its significant contributions to the advancement of effective treatments. Noteworthy developments include the creation of the Bionic Pancreas (in partnership with Boston University), implantable insulin pumps, and innovative techniques for assessing long-term glucose control. Additionally, the GLP-1 was first tested in human subjects at the MGH Diabetes Research Center.

Researchers at Massachusetts General Hospital have led pivotal studies in disease and complication prevention, including the highly cited Diabetes Control and Complications Trial (DCCT) and the Diabetes Prevention Program. Ongoing research continues to build upon foundational work in the Diabetes Research Center, focusing on evidence generation across all types of diabetes, atypical presentations, diverse populations, epidemiology, genetics, precision medicine, individuals who are pregnant or lactating, and complication prevention. The availability of dedicated research examination rooms and laboratory facilities enables efficient processing and shipment of biological samples, thereby expediting study workflows and results.

Our Team

Our interdisciplinary team comprises physicians, bench scientists, epidemiologists, statisticians, dietitians, nurses, clinical research coordinators, research technicians, students, and research fellows. This collective expertise supports our mission to advance the diagnosis, prevention, and treatment of all forms of diabetes and their associated complications.

Collaborations

We maintain collaborative partnerships with academic and industry researchers worldwide. Current collaborations include the Mass General Brigham Center for Genomic Medicine, the Broad Institute, and the Boston Area Diabetes Endocrinology Research Centers (BADERC). For inquiries regarding future collaborations, please contact us.

Group Members

Our researchers include epidemiologists, physicians, bench scientists, dietitians and nurses.

Clinical Investigators

Clinical Research Dietitians

Publications

View recent publications from the Diabetes Clinical and Translational Research Center. Some full-text articles may require a subscription.

Research Projects

The Diabetes Research Center is actively conducting clinical trials in areas such as cystic fibrosis-related diabetes, gestational diabetes, tumor-associated hyperinsulinism (tHI), rare and atypical diabetes, type 1 and type 2 diabetes, and lifestyle interventions targeting disease prevention.

For details on ongoing trials, visit rally.massgeneralbrigham.org and for a summary of our trials, see below.

For information about the MGH Diabetes Center Repository, visit here.

Diabetes Research Center Current and Past Trials

Selected current, recent, and past trials are listed below.

Currently enrolling, upcoming, and recent trials
  • BIONIC-CF (Bionic Pancreas for the treatment of cystic fibrosis related diabetes): Randomized clinical trial investigating the safety and efficacy of the Ilet bionic pancreas in adolescents and adults with cystic fibrosis related diabetes (CFRD) https://rally.massgeneralbrigham.org/study/bpcfrd2024
  • STRONG-CF (Strength and muscle related outcomes for nutrition and lung function in cystic fibrosis): Longitudinal observational study assessing novel nutrition and sarcopenia outcomes in adults with CF
  • DECIDE: Comparing the Effectiveness of Oral Metformin vs. Injectable Insulin for the Treatment of Gestational Diabetes. https://rally.massgeneralbrigham.org/study/decide
  • GAPS: GLP-1 receptor Agonist in Pregnancy Study https://rally.massgeneralbrigham.org/study/gaps
  • T1D Pregnancy and Me: https://rally.massgeneralbrigham.org/study/t1dpregnancyandme
  • Rezolute- RZ358-302, A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ersodetug in Patients with Adequately Controlled Hypoglycemia Due to Tumor-Associated Hyperinsulinism (tHI)
  • RADIANT: Study to understand rare and atypical forms of diabetes using genetic sequencing and clinical testing
  • Ready to take charge of your health? Join the Path to Lifestyle Change
  • SPECTRUM (Studying the presence of CFRD complications with thoughtful recruitment of multiethnic minoritized groups): Cross sectional study to learn about diabetes complications occurring in adolescents and adults with CFRD
  • PREPARE4AID (PRimary CarE PrAgmatic, Real World Experience for Automated Insulin Delivery): In collaboration with investigators at the University of Colorado, this randomized clinical trial assesses the performance of the iLet Bionic Pancreas in adults with type 1 and type 2 diabetes when the AID system is deployed and managed by community-based primary care physicians using a telehealth-based approach.
  • BICEP (BIA monitoring and exercise for the prevention of muscle loss with incretin therapy): Randomized clinical trial investigating a wearable fitness monitor/smartwatch in optimizing body composition in adults starting treatment with GLP1 receptor agonist therapy.
Clinical trials (in follow-up)
Notable past research clinical trials
  • Diabetes Control and Complications Trial (DCCT): Hailed as the one of the most important studies in diabetes since the discovery of insulin, the DCCT demonstrated the primacy of intensive metabolic control in preventing the development of complications in type 1 diabetes and established Mass General as one of the premier centers for the study of type 1 diabetes and its complications.
  • Implantable Pump Project: an international study lead by Mass General investigators that established the utility of an implantable pump (first developed by Mass General investigators, in the treatment of type 1 diabetes.)
  • Whole organ transplantation: the first program in New England to establish a high rate of success and safety of simultaneous kidney/pancreas transplantation.
  • Islet transplantation: the first successful isolation and purification of human islets in New England with subsequent transplantation
  • Diabetes Prevention Program (DPP): A multicenter, NIH-sponsored study, led by MGH investigators, that established the means of preventing type 2 diabetes.
  • Immune Tolerance Network Study: an international study investigating islet transplantation as a treatment of type 1 diabetes and established a 75% success rate in normalizing blood sugar control in type 1 diabetes.
  • LookAHEAD Study: Reported many benefits of lifestyle intervention on myriad outcomes in type 2 diabetes.
  • SUGAR-MGH and PHARMGen: Determination of the effect of genetic background on responsiveness to different treatments of type 2 diabetes, to introduce precision medicine
  • TODAY: Study of the best means to treat type 2 diabetes in children and adolescents
  • GRADE Study: Study to determine the most effective glucose-lowering drug added to metformin in type 2 diabetes
  • REAL HEALTH-Diabetes: Study to test effectiveness of group lifestyle intervention (diet and exercise program) based in primary care in the community on weight loss and diabetes outcomes in type 2 diabetes
  • GO MOMs (GO MOMs Study Home – Glycemic Observation and Metabolic Outcomes in Mothers and Offspring): Study of blood sugar levels during pregnancy that is using continuous glucose monitoring and developing new ways to test for gestational diabetes
  • Closed loop pump therapy of type 1 diabetes: Development of an artificial pancreas for the treatment of type 1 diabetes